Abeona Therapeutics CFO Joseph Vazzano Sells 49,338 Shares Under 10b5-1 Plan

Abeona Therapeutics Inc. CFO Joseph Vazzano filed a Form 4 disclosing the sale of 49,338 common shares over two days in June 2026, reducing his holdings from 567,505 to 518,437 shares. The transactions included 10,271 shares sold on June 8 at a weighted average price of $5.4295 to cover tax obligations from vested restricted stock, and additional sales of 13,421 and 25,646 shares on June 9 at weighted average prices of $5.3042 and $5.3922 respectively. The June 9 sales were executed pursuant to a Rule 10b5-1 trading plan adopted on January 21, 2026. The sales were conducted in multiple transactions within specified price ranges, with the reporting person undertaking to provide detailed transaction information upon request. Following these transactions, Vazzano maintains a significant ownership position of 518,437 shares in the company.